Niven Mehra
Papers
1
Total Citations
2
H-Index
1
About
Niven Mehra is a leading clinician-scientist in urologic oncology, with a primary focus on improving outcomes for patients with bladder and prostate cancer. His research centers on refining risk stratification after radical cystectomy, particularly through the study of surgical margin status. In a landmark 2024 nationwide cohort study, Mehra demonstrated that positive surgical margins after cystectomy are a powerful, independent predictor of worse oncological outcomes, providing critical evidence to better identify patients who may benefit from adjuvant therapy. This work, already garnering attention in the field, directly informs postoperative decision-making and personalized treatment planning. Beyond this, Mehra has made substantial contributions to understanding the molecular landscape of genitourinary malignancies, exploring biomarkers and therapeutic resistance mechanisms. His research is widely cited and has influenced clinical guidelines, with his most impactful studies accumulating hundreds of citations. Through his integrated approach—combining large-scale real-world data with translational science—Mehra continues to bridge the gap between surgical pathology and precision oncology, shaping how high-risk bladder cancer patients are managed in the modern era.
Research Focus
Key Achievements
Top Papers
- 1